---
figid: PMC7037210__ijms-21-00747-g001
figtitle: Main anticancer molecular mechanisms mediated by cannabinoid receptors’
  activation “↑, upregulation” and “↓, downregulation”
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Cannabis sativa
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7037210
filename: ijms-21-00747-g001.jpg
figlink: pmc/articles/PMC7037210/figure/ijms-21-00747-f001/
number: F1
caption: Schematic representation of the main anticancer molecular mechanisms mediated
  by cannabinoid receptors’ activation “↑, upregulation” and “↓, downregulation”.
  Cannabinoid receptor (CB-R) agonists inhibit cancer cell proliferation through various
  receptor-mediated mechanisms. CB-R agonist induces cancer cell death via apoptosis,
  mediated by the activation of different transcription factors (proapoptotic Bcl2
  family transcription factor and mitogen-activated protein kinase (MAPK) pathway)
  and de novo synthesis of ceramide and reactive oxygen species (ROS) production.
  CBs block cancer cells’ proliferation by inhibiting extracellular signal regulated
  kinase (ERK) signaling. They also reduce cell migration and angiogenesis, inhibiting
  the focal adhesion kinase/proto-oncogene tyrosine-protein kinase Src/transforming
  protein RhoA (FAK/SRC/RhoA) pathway. CBs prevent cancer epithelial mesenchymal transition
  (EMT), inhibiting Wnt/β-catenin pathway, and induce autophagy by activation of mammalian
  target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways. CBs
  can impair stemness and cancer stem cells’ (CSCs) self-renewal. (Akt (protein kinase
  B), PI3K (phosphoinositol-3-kinase) Raf (serine/threonine-protein kinase)).
papertitle: 'The Endocannabinoid System: A Target for Cancer Treatment.'
reftext: Chiara Laezza, et al. Int J Mol Sci. 2020 Feb;21(3):747.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9435195
figid_alias: PMC7037210__F1
figtype: Figure
redirect_from: /figures/PMC7037210__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7037210__ijms-21-00747-g001.html
  '@type': Dataset
  description: Schematic representation of the main anticancer molecular mechanisms
    mediated by cannabinoid receptors’ activation “↑, upregulation” and “↓, downregulation”.
    Cannabinoid receptor (CB-R) agonists inhibit cancer cell proliferation through
    various receptor-mediated mechanisms. CB-R agonist induces cancer cell death via
    apoptosis, mediated by the activation of different transcription factors (proapoptotic
    Bcl2 family transcription factor and mitogen-activated protein kinase (MAPK) pathway)
    and de novo synthesis of ceramide and reactive oxygen species (ROS) production.
    CBs block cancer cells’ proliferation by inhibiting extracellular signal regulated
    kinase (ERK) signaling. They also reduce cell migration and angiogenesis, inhibiting
    the focal adhesion kinase/proto-oncogene tyrosine-protein kinase Src/transforming
    protein RhoA (FAK/SRC/RhoA) pathway. CBs prevent cancer epithelial mesenchymal
    transition (EMT), inhibiting Wnt/β-catenin pathway, and induce autophagy by activation
    of mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK)
    pathways. CBs can impair stemness and cancer stem cells’ (CSCs) self-renewal.
    (Akt (protein kinase B), PI3K (phosphoinositol-3-kinase) Raf (serine/threonine-protein
    kinase)).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cnr1
  - Ctnnb1
  - Akt1
  - Pik3r1
  - Cdh1
  - Fzr1
  - Snai1
  - Twist1
  - Snai2
  - Ptk2
  - Zhx2
  - Src
  - Bad
  - Rhoa
  - Ephb2
  - Mapk1
  - Mapk3
  - Mtor
  - Itk
  - Slc22a3
  - Bax
  - Nkx3-1
  - Ddit3
  - Atf4
  - Mp
  - Syf2
  - Gm4736
  - Prh1
  - Slc10a5
  - Prb1b
  - Parp1
  - Trib3
  - Tas2r140
  - Vegfa
  - Cbr1
  - Prkaa2
  - Pik3cg
  - Ephb1
  - Ccne1
  - CNR1
  - CTNNB1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDH1
  - FZR1
  - SNAI1
  - TWIST1
  - SNAI2
  - PTK2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SRC
  - FGR
  - FYN
  - YES1
  - BAD
  - RHOA
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - ITK
  - SLC22A3
  - BAX
  - DDIT3
  - ATF4
  - PMP2
  - TPSP1
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - TAS2R13
  - TRIB3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - cb
  - dv
  - wat
  - arm
  - SNF4Agamma
  - AMPKalpha
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - shg
  - sna
  - twi
  - slug
  - Fak
  - Raf
  - Src42A
  - Csk
  - Src64B
  - cass
  - Rho1
  - Erk7
  - rl
  - Tor
  - crc
  - Sp7
  - Parp
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - CycE
  - cyc
---
